| CZH1713A is a provitamin A hybrid that has good yield potential under optimum, managed drought and Low nitrogen stress conditions with good disease resistance to GLS, TLB and Rust. The hybrid also has good producibility with good female and pollen parent yield potential. |
|
General Information |
| |
Adaptation/Agroecological zone |
600-1500 masl |
| |
Region |
Southern Africa |
| |
Type of product |
Three-way Cross |
| |
Year first announced |
2019 |
| |
|
|
| |
Grain Characteristics |
| |
|
|
Grain color |
Orange |
| Grain Yield |
|
Grain texture |
Flint |
| Grain yield (MEA) (OPT) |
9.9 t/ha |
|
PVA content |
9.1 µg/g |
| Grain yield (MEB) (OPT) |
4.5 t/ha |
|
|
|
| Grain yield (MEA) (HD) |
9.8 t/ha |
|
Biotic Stress Performance |
| Grain yield under drought stress |
3.8 t/ha |
|
Turcicum leaf blight (TLB) (1-9) |
4.0 |
| Grain yield under low N stress (NUE) |
3.2 t/ha |
|
Rust (1-9) |
1.8 |
| |
|
|
Grey leaf spot (GLS) (1-9) |
3.8 |
| Agronomic Characteristics |
|
Ear rot |
4.2% |
| Maturity |
130 DAP |
|
Diseases were originally scored on a 1-5 scale but have been converted here to a 1-9 scale, where 1 = Highly resistant; 5 = Tolerant; 9 = Highly susceptible. |
| Anthesis-silking interval |
1.3 Days |
|
| Bad husk cover |
6.1% |
|
|
|
| Ears per plant |
1.2 |
|
Seed Production Characteristics |
| Ear aspect (1-5) |
2.4 |
|
Female seed yield |
14.0 t/ha |
| Ear height |
103.8 cm |
|
Male seed yield |
3.3 t/ha |
| Plant aspect (1-5) |
2.5 |
|
Nicking |
2.0 Days |
| Plant height |
203.7 cm |
|
|
|
| Plant and ear aspects are scored on 1-5 scale, where 1 = desirable and 5 = undesirable characteristics |
|
Comments |
| |
Product information is based on data from the CIMMYT Southern Africa Maize Regional On-Station 2018 Trials.
Abbreviations:
DAP = Days After Planting
DLL = Dry Lowlands
DMA = Dry Mid-Altitudes
GLS = Grey Leaf Spot
masl=Meters above sea level
MEA = Mega-environment A
MEB = Mega-environment B
MSV = maize streak virus
NUE = Nitrogen Use Efficient
TLB = Turcicum Leaf Blight |
| |
|
|
| Further Links |
|
| Full Announcement |
|
| Regional Trial Data Summary |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
